RadNet, Inc. (RDNT) vs Travere Therapeutics, Inc. (TVTX)
A side-by-side comparison of RadNet, Inc. and Travere Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
RDNT
RadNet, Inc.
$70.28HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
TVTX
Travere Therapeutics, Inc.
$55.98HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — RDNT vs TVTX
growth of $100 · dividends reinvested · last 10yRDNT +882.9% (+25.7%/yr)TVTX +150.2% (+9.6%/yr)RDNT compounded faster over this window
RDNT TVTX
RDNT vs TVTX: by the numbers
- •RDNT is the larger company ($5.53B vs $5.21B market cap).
- •Both run net losses; RDNT's is the smaller (-0.93% vs -7.35% net margin).
- •TVTX grew revenue faster over the past five years (23.71% vs 12.68% CAGR).
Metrics side by side
Valuation
| Metric | RDNT | TVTX |
|---|---|---|
| Forward P/E | 136.65 | N/A |
| P/S ratio | 2.44 | 8.80 |
| P/B ratio | 5.04 | 212.29 |
| EV / EBITDA | 21.70 | 248.98 |
| FCF yield | N/A | 0.99% |
Profitability
| Metric | RDNT | TVTX |
|---|---|---|
| Gross margin | 9.70% | 94.41% |
| Operating margin | 4.00% | -6.84% |
| Net margin | -0.93% | -7.35% |
| ROE | -1.93% | -177.24% |
| ROIC | 1.41% | -6.19% |
Growth (annualized)
| Metric | RDNT | TVTX |
|---|---|---|
| Revenue CAGR (5Y) | 12.68% | 23.71% |
| Total return CAGR (5Y) | 19.72% | 17.83% |
Frequently asked
- Which has grown faster, RDNT or TVTX?
- Over the past five years, TVTX grew revenue faster — RDNT at a 12.68% CAGR versus TVTX at 23.71%.
- How have RDNT and TVTX total returns compared?
- Over the past 10 years, RDNT delivered 25.20% and TVTX delivered 9.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
RadNet ROETravere Therapeutics ROERadNet operating marginTravere Therapeutics operating marginRadNet revenue growthTravere Therapeutics revenue growthRadNet free cash flowTravere Therapeutics free cash flow
RadNet & Travere Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.